Antibody Engineering Company F-Star Buys Back Royalty Obligations
|
|
f-star, an antibody engineering company developing novel antibodies and antibody fragments based on its unique Modular Antibody Technology, announced today that it has acquired future royalty obligations to New Century Pharmaceuticals via a one-off payment. ....click the link to read more
|
|
Monday 31 March, 2008 02:24 PM |